175

Dermatology
Focus on skin health and related diseases.
Sub Categories on Dermatology
Latest Articles
Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

by Elana GotkineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea comp

Direct calcitonin gene-related peptide inhibition found to reduce acne, rosacea in patients with migraine

by Elana GotkineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea comp
Study examines role of the gene TRPV4 in regulating perspiration in mice

Study examines role of the gene TRPV4 in regulating perspiration in mice

by National Institute for Physiological SciencesRepresentative TRPV4 staining in sweat glands from normohidrotic and anhidrotic skin from the same patient with acquired idiopathic generalized anhidros

Study examines role of the gene TRPV4 in regulating perspiration in mice

by National Institute for Physiological SciencesRepresentative TRPV4 staining in sweat glands from normohidrotic and anhidrotic skin from the same patient with acquired idiopathic generalized anhidros
Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432
Prevalence of skin cancer varies for sexual minority, heterosexual adults

Prevalence of skin cancer varies for sexual minority, heterosexual adults

by Elana GotkineWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published

Prevalence of skin cancer varies for sexual minority, heterosexual adults

by Elana GotkineWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published
AI tool could dramatically decrease diagnostic times for psoriatic arthritis patients

AI tool could dramatically decrease diagnostic times for psoriatic arthritis patients

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainResearchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic arthritis

AI tool could dramatically decrease diagnostic times for psoriatic arthritis patients

by European Academy of Dermatology and VenereologyCredit: Unsplash/CC0 Public DomainResearchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic arthritis
FDA approves Zoryve for atopic dermatitis

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p
Long-term upadacitinib use feasible for adolescents with atopic dermatitis

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23
Melanoma risk from biologic therapy remains uncertain

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev
FDA approves Leqselvi for severe alopecia

FDA approves Leqselvi for severe alopecia

by Lori SolomonThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral select

FDA approves Leqselvi for severe alopecia

by Lori SolomonThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral select
Study finds link between eczema and peripheral vascular disease

Study finds link between eczema and peripheral vascular disease

byYale School of MedicineCredit: Unsplash/CC0 Public DomainPeople living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular disease (

Study finds link between eczema and peripheral vascular disease

byYale School of MedicineCredit: Unsplash/CC0 Public DomainPeople living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular disease (